Welcome to Day 2 of LCGC?s coverage of Pittcon 2011. Today, we present the 2011 Emerging Leader Award as part of our live theater, in booth #3217, at 10:00 a.m.
Welcome to Day 2 of LCGC’s coverage of Pittcon 2011. Today, we present the 2011 Emerging Leader Award as part of our live theater, in booth #3217, at 10:00 a.m. We are also proud to continue our theater program, focusing on hyphenated techniques.
The winner of the 2011 LCGC Emerging Leader award is Dwight R. Stoll, Assistant Professor at Gustavus Adolphus College, in Saint Peter, Minnesota. Stoll has developed fast, comprehensive two‐dimensional high performance liquid chromatography (c2D‐HPLC) as an analytical tool capable of quickly separating and quantifying hundreds of chemical constituents of complex mixtures. Stoll designed and built a 2D-LC instrument that has many unique features and made it possible to do comprehensive 2D-LC with a peak capacity of more than 1000 in 30 min. Such peak capacities have a separating capacity equivalent to several hundred thousand plates in 1D-LC. His laboratory is now working on 3D-HPLC, and has developed systems capable of quantifying compounds at ppb levels in complex matrices with minimal sample preparation and method development for each new analyte-matrix combination encountered.
Following the Emerging Leader interview, our morning theater schedule focuses on hyphenated techniques. At 10:30 a.m., Hernan Cortes of Hernan Cortes Consulting will discuss polymer analysis using multidimensional chromatography combined with mass spectrometry. At 11:00 a.m., Luigi Mondello of the University of Messina will address food sample analysis using comprehensive GCxGC with MS. We will wrap up the morning session with an 11:30 a.m. interview with Sam Yang of the University of Texas at Arlington about LC–MS with online sample preparation to survey metabolites formed in vitro.
We hope you will join us in booth #3217 for these interviews.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.